Remove Biotechnology Remove CTO Remove Programming
article thumbnail

Sana Biotechnology cuts the ribbon at new manufacturing facility near Seattle

GeekWire

Sana Biotechnology CEO Steve Harr cuts the ribbon at the company’s new manufacturing facility in Bothell, Wash., Suzan DelBene, Bothell Mayor Mason Thompson, and Sana CTO Snehal Patel also participated in the ceremony. The Bothell facility will house Sana’s proprietary cancer drug program. Washington state Rep.

article thumbnail

Tech Moves: Adaptive Biotechnologies COO departing; Sana adds leaders; and more

GeekWire

Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies , the company said today in a regulatory filing. He was first hired by Adaptive as chief technology officer. Sana Biotechnology named two new research leaders. Mark Adams.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tech Moves: F5 adds CTO and HR chief; Adaptive names CFO; Techstars Seattle leaders depart

GeekWire

F5 Chief People Officer Lyra Schramm (left) and Chief Technology Officer Kunal Anand. (F5 F5 Photos) — Seattle-based application security and delivery giant F5 announced two new executive appointments this week: Lyra Schramm , the company’s new chief people officer, and Kunal Anand , chief technology officer.

article thumbnail

Tech Moves: Amazon’s director of Alexa Trust; BECU adds CIO; Lockstep, Fabric exit stealth mode

GeekWire

The founding team includes: • CEO Peter Horadan, previously EVP of engineering and CTO at tax automation startup Avalara. Chief Strategy Officer Matthew Shanahan , previously chief operating and innovation officer at Globys, a software company offering digital billing products. Nautilus Biotechnology Photo).

article thumbnail

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs

GeekWire

He’s now CEO of Nautilus Biotechnology, and he’s not taking any big chances in the current economic downturn. Earlier companies are considering fewer development programs and having a slower ramp on hiring. Neoleukin Therapeutics recently shed staff in the wake of disappointing clinical data for its lead program, for example.

Industry 109
article thumbnail

Thanks Darpa: Minimally Invasive “Stentrode” Shows Potential as Neural Interface for Brain

CTOvision

The technology was developed under DARPA’s Reliable Neural-Interface Technology (RE-NET) program , and offers new potential for safely expanding the use of brain-machine interfaces (BMIs) to treat physical disabilities and neurological disorders.

.Net 150
article thumbnail

Biotech giant Moderna will open tech office in Seattle, plans to hire up to 220 workers

GeekWire

The news is a bright spot for Seattle’s biopharma scene which has seen employee cuts at several biotech companies recently as part of wider layoffs in the industry, including at NanoString Technologies , Sana Biotechnology , Eliem Therapeutics and Neoleukin Therapeutics. It reported $19.3 billion in revenue for 2022, up from $18.5